project id: TCGA-PAAD; case submitter id: TCGA-YY-A8LH; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.38; rna integrity number: 7.2; age at index: 61; days to birth: -22376; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1948; age at diagnosis: 22376; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2016.0; icd 10 code: C25.0; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Tail of pancreas; synchronous malignancy: No; tissue or organ of origin: Tail of pancreas; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 2.5205479452054793; pack years smoked: 46.0; is ffpe: false; composition: Not Reported; days to collection: 1717; days to sample procurement: 0; initial weight: 150.0; portion submitter id: TCGA-YY-A8LH-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 10.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 50.0; percent tumor cells: 40.0; percent tumor nuclei: 40.0;